left-hand column, the expressions [1 + 2nS(r) sin2 9]1/2 in the relativistic solutions should be replaced by [1 + 2772S(r) sin2 O]1/2, and the last term should read F(I) = I + (1/2)17I2.
In Eq. 44, an editorial error was made. The correct equation is: p(O) = p(a) -2c2,uon2K2 > p(a) -(1/2)c2go [44] In Eqs. 45 Correction. In the article "Intramolecular ciosslinking of tropomyosin via disulfide bond formation: Evidence for chain register" by Sherwin S. Lehrer, which appeared in the September 1975 issue of the Proc. Natl. Acad. Sci. USA 72, 3377-3381, the author has requested the following changes. On page 3380, lines 10 and 11 in the right-hand column should read, "A mixture only of aa and a# chains would, .. On the same page, lines 17 and 18 in the right-hand column should read, "For the aa, af3 model the ratios would be (0.5, 0.5) and (0.6, 0.4) for a/fl = 3 and 4, respectively."
Correction. In the article "Determination of the number of superhelical turns in simian virus 40 DNA by gel electrophoresis" by W. Keller, which appeared in the December 1975 issue of Proc. Natl. Acad. Sct. USA 72, 4876-4880, the author has requested the following change. On page 4879, in the sentence beginning on the tenth line of the right column, the two minus signs should be deleted. The corrected sentence is "For SV40 DNA this amounts to a reduction of r by 0.62.5200/360 = 9 turns." Corrections Proc. Natl. Acad. Sci. USA 73 (1976) 2527 Addendum. To the paper "Purification of folate binding factor in normal umbilical cord serum" by Barton A. Kamen and J. Douglas Caston, which appeared in the November 1975 issue of Proc. Natl. Acad. Sci. USA 72,4261-4264, the following note is added.
The method for dissociation of endogenous bound folate from the natural folate-binder complex was essentially that used initially in the isolation and characterization of folate binder from hog kidney (1, 2) and subsequently employed in the discovery of a folate-binder complex in serum (3) . It is a modification of an approach used to dissociate the synthetically produced folate-binder complex with the binder found in bovine milk, which was shown by Ford et al. (4) to have a strong pH dependency for association-dissociation equilibrium. Oxidized folates were bound in preference to reduced derivatives, but only three to four times more unlabeled 5-methyltetrahydrofolic acid than pteroylglutamic acid was required to produce an equal level of competition. The strong affinity for 5-methyltetrahydrofolic aci4, the main serum folate, suggests that the binder could be part of a mechanism by which the fetus concentrates maternally supplied folate for its growth and development.
Recent studies using a radiochemical ligand binding procedure demonstrated that most sera contain a pool bf bound folate (1) . In general, the amount of bound folate is small, less than 5 ng of 5-methyltetrahydrofolic acid equivalents/ ml of serum. This limitation in supply has thwarted systematic study of serum folate binding factors except in a few pathologic conditions in which "unsaturated binder" was found in the serum (2, 3) . Measurements in our laboratory on matched maternal and neonatal (or umbilical cord) serum samples showed that the levels of free folate in the matched samples were similar, whereas the level of bound folate in the neonatal circulation was four to five times greater than that in the maternal serum (Table 1) . This source of folate-binder complex has provided an adequate amount of material for preparation of unsaturated binding factor. This paper reports on the disassociation of endogenous folate-binder complex and the separation of folate from the binder. Also included are our preliminary findings on some physical and chemical properties of the binding factor.
MATERIALS AND METHODS Umbilical cord blood was drawn from the umbilical vein immediately after delivery of the placenta of full term neonates (i.e., those with a birth weight of at least 2500 g). Maternal blood was obtained at random upon admission of expectant mothers to the hospital for the purpose of childbirth.
Serum samples were prepared and assayed for folate as described previously (1) . Individual samples were then pooled and stored at -40°until used. Folate values are expressed as 5-methyltetrahydrofolic acid equivalents unless otherwise stated.
Endogenous bound folate was dissociated from the natural folate-binder complex by treatment with acid pH. The freed folate was then adsorbed onto charcoal, thus leaving the unsaturated binder in solution. All steps were carried out at 40 unless otherwise stated. Specifically, the pH of the serum was adjusted slowly to 3-3.2 with 1 M citric acid; then 5 mg of Norit A (Matheson, Coleman, and Bell) were added to each ml of serum (starting volume). The suspension was stirred slowly overnight and then centrifuged for 15 min at 12,000 X g to pellet the charcoal. The supernatant fluid was slowly adjusted to pH 7.4 with 1 N NaOH. Any precipitate was removed by centrifugation as above and discarded. Aliquots of the neutralized supernatant fluid were then ana- Using the general approach reported by Salter et al. (5) for milk and modified by Selhub and Grossowicz (6), the separated binder was concentrated and purified approximately 10,000-fold by affinity chromatography and Sephadex G'100 filtration. Neutralized extracts of serum containing the now unsaturated binder were passed through a 1 X 7 cm column of AH-Sepharose 4B (Pharmacia) to which methotrexate (2-amino, 4-amino, 4-deoxy-10-methyl-pteroylglutamic acid; Lederele) had been covalently linked according to methods presented by Newbold and Harding (7) and that had been equilibrated with 0.05 M potassium phosphate buffer, pH 7.6. More than 90% of the PteGlu binding activity adhered to the column on the first passage. After washing the column with 0.05 M potassium phosphate buffer until no detectable material absorbing at 280 nm was eluted, binder was eluted in about 90 ml of 0.2 N acetic acid. The eluant was then concentrated to about 10 ml by lyophilization and 5 ml aliquots were filtered through a 2.5 X 90 cm Sephadex G-100 column equilibrated in 0.1 M ammonium bicarbonate. Peak fractions of binding activity (Fig. 3) were pooled, lyophilized to dryness, and dissolved in 0.05 M potassium phosphate buffer, pH 7.6. The results of this purification are shown in Table 2 .
Analyses of binding specificity and affinity were done according to methods described for the binding factor from hog kidney (4). "Bound" and "free" folate were separated by adsorption of the free folate onto charcoal coated with albumin (4), by zonal centrifugation through sucrose gradients, or by filtration through Sephadex G-25 or G-100 ( § Pooled serum was extracted with acid, treated with charcoal, neutralized, and purified by affinity chromatography and filtration through Sephadex G-100.
3). Binding capacity was determined by subsaturating concentrations of binder as detailed elsewhere (4). Reduced folate derivatives used in this study were synthetically prepared and were all d,l isomers.
RESULTS
Analysis of 15 samples of umbilical cord serum and matched maternal serum showed no significant differences with respect to free folate content. In contrast, the bound fraction of folate was four to five times greater in the cord serum than in the matched sample of maternal serum (Table 1) tested. This means that none of the cord serum samples contained endogenous "unsaturated" binder.
After acid extraction and charcoal treatment, the pooled cord serum contained no detectable folate and showed a binding capacity of 1.2 ng of PteGlu per ml (Table 1) . This compared with a pre-treatment value of bound folate of 12 ng/ml. Assuming bound folate and binding capacity to be equivalent, this would represent a recovery of 10%. The results of the treatment and purification procedure are summarized in Table 2 As shown by competition experiments, the separated binding factor preferred oxidized folates to reduced derivatives (Fig. 1) . The binding factor did, however, show strong binding affinity for 5-methyltetrahydrofolic acid. Note that only 3.5-4 pmol of 5-methyltetrahydrofolic acid produced the same degree of competition for the binding of [3H]PtoGlu as 1 pmol of PteGlu. In contrast, the affinity of the binder for 5-formyltetrahydrofolic acid and methotrexate was slight, about 30 and 20 pmol, respectively, being required to equal the competition of 1 pmol of PteGlu. In addition, high concentrations of folate analogs such as p-aminobenzoylglutamic acid and 6-carboxypterin did not inhibit the binding of [3H]PteGlu. Finally, changes in the number of glutamic acid residues did not appreciably alter the binding affinity.
Although the factor showed binding determinants for 5-methyltetrahydrofolic acid, at pH 7.6 the affinity for this derivative was somewhat lower than that for PteGlu. This was more clearly seen by sequential binding measurements (Fig. 2) . Regardless of the temperature, [3H]PteGlu did not displace unlabeled PteGlu. However, at room temperature 5-methyltetrahydrofolic acid was displaced by [3H]PteGlu at the rate of 0.3%/min. At 4°, the rate of this displacement was less than 0.1%/min.
The binder, either saturated or unsaturated with PteGlu, has an apparent molecular weight of 40,000 as judged by Sephadex G-200 and G-100 chromatography in 0.1 M potassium phosphate buffer, pH 7.6. Zonal centrifugation through 3-15% sucrose gradients in the same buffer gave results consistent with the 40,000 molecular weight value (Fig. 3) .
The binding of PteGlu showed strong pH dependency, as has been the case with binders of folate from other sources (2, 4, 10 (2-4, 8, 9) , their function is not known. Johns et al. suggested that specific carriers of folate must exist to account for the rapid plasma clearance and cellular uptake of this cofactor (10). Lichtenstein et al. described a carrier-mediated, saturable transport system for folate in culture L1210 cells (11) . Also, Ford and Salter reported some of the properties of unsaturated binder in bovine and human milk (12) . Markkanen et al. (13) demonstrated that serum folate, as judged by growth of Lactobacillus casei in a microbiological assay, fractionated on Sephadex G-200 into three bands of high molecular weight in addition to the major low-molecularweight fraction that corresponded to "free" folate. When chromatographed on DEAE-Sephadex A-50, the "L. case4
activity" appeared in the a2-macroglobulin and transferrin regions (14) . More recently several laboratories have described some properties of "serum folate binder" from a few patients with chronic granulocytic leukemia (2) or folate deficiency (3) and from some pregnant women and women taking oral contraceptives (15) . Binding factor in these cases apparently existed in an "unsaturated" state in the serum.
The level of endogenous, saturated binder was not assessed in those studies, however.
This report shows that endogenously bound serum folate can be dissociated from a specific binding factor and subsequently removed from the serum. The unsaturated binder can then react with [3H]PteGlu and other folate derivatives. This facilitates the study of its binding specificity, affinity, and other physical and chemical properties. The low recov-ery of endogenous binder shown in Table 1 may be a reflection of several problems. No doubt conditions used to dissociate the folate-binder complex and to produce and concentrate unsaturated binder contributed to the low yield of separated binder.
The molecular weight of 40,000 for the separated binder from cord serum is similar to that of binder from hog kidney (4) and milk (12, *). Also, the binding preference at pH 7.6, mole PteGlu bound: mole 5-methyltetrahydrofolic acid bound, of 3.5-4:1 for cord serum is intermediate between the 6:1 for milk binder* and the 2:1 for hog kidney binder (4). Moreover, neither hog kidney nor cord serum binder has great affinity for 5-formyltetrahydrofolic acid or methotrexate. However, the cord serum binder differs appreciably from the hog kidney factor in the displacement of 5-methyltetrahydrofolic acid by PteGlu. Only insignificant displacement was noted with the hog kidney factor, whereas a displacement of about 0.3%/min occurred with the cord serum factor at 210. The binding factor in cord serum also differs from the "unsaturated" binder reported in serum of some pregnant women (15) . The latter failed to bind 5-methyltetrahydrofolic acid. Whether those sera also contained a "saturated" binder that could bind 5-methyltetrahydrofolic acid has not yet been ascertained.
The binding of 5-methyltetrahydrofolic acid by the factor in cord serum, and the high concentration of the saturated factor in neonatal relative to maternal circulation presents a possible molecular mechanism by which the fetus can sequester and concentrate folate across the placenta from the maternal circulation. More 
